Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation - ScienceDirectdoi:10.1016/j.jvir.2018.12.607M. Jimenez Exposito...
基于CheckMate -649研究结果,纳武利尤单抗联合化疗一线治疗晚期胃癌获得显著生存获益,该方案成为首个且目前唯一在中国获批用于晚期胃癌一线的免疫疗法,无论PD-L1表达。 基于CheckMate -648数据,纳武利尤单抗联合化疗以及双免疫无化疗方案全面开花,总生存...
2. Antonia SJ, López-Martin JA, Bendell J,et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-celllung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.LancetOncol2016; published online Ju...
2020年9月25日,日本乐天医疗宣布其全资子公司乐天医药(Rakuten Medical)的光免疫疗法药物Akalux(ASP-1929)联合BioBlade激光系统医疗器械获得日本厚生劳动省批准上市,用于治疗不可切除的局部晚期或复发性头颈癌。Akalux® IV Infusion 250mg(cetuximab saratolacan sodium) 研发代码ASP-1929 ,是由西妥昔单抗(cetuximab)...
Seriousblack31 (366)vs.Waka_kuru (337) 1-0Live ChessChess.com29 Dec 2024ECO: A40 87654321abcdefgh 1. d4 e5 2. dxe5 f6 3. exf6 Nxf6 4. Bg5 Be7 5. Bxf6 gxf6 6. Nf3 Bb4+ 7. c3 Bc5 8. b4 Bd6 9. Na3 f5 10. ...
As part of its broad clinical program, Opdivo is being studied by the company across multiple settings and lines of therapy for HCC, including as monotherapy in the adjuvant setting (CheckMate -9DX [NCT03383458]...
(9. g3!) and Black immediately follows up with (9. fxg3). In the usual lines where this can happen in the Vienna Game, Black will often end up capturing White’s h1-rook with promotion to a new queen. In this specific game, it looks like Black would be able to force a trade ...
Response to the Letter to the Editor Titled "First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA" 来自 dx.doi.org 喜欢 0 阅读量: 13 作者: LG Paz-Ares DOI: 10.1016/j.jtho.2023.05.022 年份: 2023 ...
Program Files doi: http://dx.doi.org/10.17632/k4pnk5wrfm.1 Licensing provisions: GPLv3 Programming language: C++, Python External routines/libraries: ROOT, Python, HepMC (optional) Pythia 8 (optional), Madgraph5_aMC@NLO (optional) Subprograms used: Delphes Nature of problem: The LHC experi...
This is a mistake as dxe4 is good for Black in the position 5... Ngf6 6. exd5 Ng4 This is an aggressive move by Maxim-BOT, but to what end? 7. h3 Qe7+ 8. Be2 ... Note: Black's g4-knight is once again hanging... 8...